biote Corp. (BTMD) - Dilution Analysis

10-Q filing | 30.6M shares outstanding

10-K filing | 31.3M shares outstanding

10-Q filing | 31.3M shares outstanding

10-Q filing | 31.5M shares outstanding

POS AM filing: This POS AM filing relates to the issuance of up to 58,565,824 shares of Class A common stock upon exercise of Exchange Rights, and the offer and sale of up to 67,289,796 shares of Class A common stock by selling securityholders, including shares issued in a private placement, shares issuable upon exercise of Exchange Rights, and shares that may be issued to Yorkville under a standby equity purchase agreement.

10-K filing | 34.3M shares outstanding

10-Q filing | 32.3M shares outstanding

10-Q filing | 33.1M shares outstanding

10-Q filing | 30.3M shares outstanding

POS AM filing: This POS AM filing registers for resale up to 5,000,000 shares of Class A common stock by YA II PN, LTD. pursuant to a standby equity purchase agreement.

POS AM filing: This POS AM filing relates to the issuance of up to 58,565,824 shares of Class A Common Stock issuable to the Members upon exercise of the Retained Biote Units pursuant to the Exchange Rights, and the offer and sale from time to time by the selling securityholders of up to 62,289,796 shares of Class A Common Stock.

10-K filing | 35.7M shares outstanding

10-Q filing | 31.0M shares outstanding

10-Q filing | 29.3M shares outstanding

10-Q filing | 20.1M shares outstanding

POS AM filing: Resale of up to 5,000,000 shares of Class A common stock by YA II PN, LTD.

POS AM filing: This POS AM filing relates to the issuance of up to 72,069,990 shares of Class A Common Stock upon exercise of warrants and exchange of Retained Biote Units and the offer and sale from time to time by the selling securityholders of up to 67,856,462 shares of Class A Common Stock and 5,566,666 warrants.

10-K filing | 19.7M shares outstanding

S-1/A filing: This is a public offering of shares of our Class A common stock by selling stockholders. The underwriters have an option to purchase additional shares.

S-1 filing: This is a public offering of shares of our Class A common stock being offered by selling stockholders.

10-Q filing | 10.0M shares outstanding

10-Q filing | 9.2M shares outstanding

S-1 filing: This S-1 filing relates to the resale of up to 5,000,000 shares of Class A common stock by YA II PN, LTD. pursuant to a standby equity purchase agreement.

S-1/A filing: This S-1/A filing registers for resale shares of Class A Common Stock and Warrants by selling securityholders, as well as the issuance of Class A Common Stock upon the exercise of warrants and exchange rights.

S-1/A filing: This S-1/A filing registers for resale up to 72,069,990 shares of Class A Common Stock and up to 67,856,462 shares of Class A Common Stock and 5,566,666 Private Placement Warrants by selling securityholders.

S-1/A filing: This S-1/A filing outlines the offering of up to 72,069,990 shares of Class A Common Stock, consisting of shares issuable upon exercise of public and private placement warrants and shares issuable to members upon exercise of retained Biote Units, as well as the resale of up to 67,856,462 shares of Class A Common Stock and 5,566,666 private placement warrants by selling securityholders.

S-1 filing: This S-1 filing relates to the issuance of Class A Common Stock upon exercise of warrants and resale of Class A Common Stock and warrants by selling securityholders.

10-Q filing | 31.8M shares outstanding

10-K filing | 31.8M shares outstanding

10-Q filing | 31.8M shares outstanding

10-Q filing | 4.3M shares outstanding

S-1/A filing: Initial public offering of units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant, with an offering price of $10.00 per unit.

S-1/A filing: This S-1/A filing relates to a proposed offering of units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant, and the sale of private placement warrants to the sponsor.

S-1 filing: This S-1 filing includes information on expenses of issuance and distribution, indemnification of directors and officers, details on Class A and Class B common stock, warrants, and potential dilution risks.